6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice

Sialic acids are terminal sugars of the cellular glycocalyx and are highly abundant in the nervous tissue. Sialylation is sensed by the innate immune system and acts as an inhibitory immune checkpoint. Aminoglycoside antibiotics such as neomycin have been shown to activate tissue macrophages and ind...

Full description

Bibliographic Details
Main Authors: Tawfik Abou Assale, Thomas Kuenzel, Tamara Schink, Anahita Shahraz, Harald Neumann, Christine Klaus
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1264060/full
_version_ 1827593060556472320
author Tawfik Abou Assale
Thomas Kuenzel
Tamara Schink
Anahita Shahraz
Harald Neumann
Christine Klaus
author_facet Tawfik Abou Assale
Thomas Kuenzel
Tamara Schink
Anahita Shahraz
Harald Neumann
Christine Klaus
author_sort Tawfik Abou Assale
collection DOAJ
description Sialic acids are terminal sugars of the cellular glycocalyx and are highly abundant in the nervous tissue. Sialylation is sensed by the innate immune system and acts as an inhibitory immune checkpoint. Aminoglycoside antibiotics such as neomycin have been shown to activate tissue macrophages and induce ototoxicity. In this study, we investigated the systemic subcutaneous application of the human milk oligosaccharide 6’-sialyllactose (6SL) as a potential therapy for neomycin-induced ototoxicity in postnatal mice. Repeated systemic treatment of mice with 6SL ameliorated neomycin-induced hearing loss and attenuated neomycin-triggered macrophage activation in the cochlear spiral ganglion. In addition, 6SL reversed the neomycin-mediated increase in gene transcription of the pro-inflammatory cytokine interleukin-1β (Il-1b) and the apoptotic/inflammatory kinase Pik3cd in the inner ear. Interestingly, neomycin application also increased the transcription of desialylating enzyme neuraminidase 3 (Neu3) in the inner ear. In vitro, we confirmed that treatment with 6SL had anti-inflammatory, anti-phagocytic, and neuroprotective effects on cultured lipopolysaccharide-challenged human THP1-macrophages. Thus, our data demonstrated that treatment with 6SL has anti-inflammatory and protective effects against neomycin-mediated macrophage activation and ototoxicity.
first_indexed 2024-03-09T02:04:38Z
format Article
id doaj.art-5cd597601eca4746ad0e505fa58496ea
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-09T02:04:38Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5cd597601eca4746ad0e505fa58496ea2023-12-07T20:56:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-12-011410.3389/fimmu.2023.126406012640606’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible miceTawfik Abou Assale0Thomas Kuenzel1Tamara Schink2Anahita Shahraz3Harald Neumann4Christine Klaus5Neural Regeneration, Institute of Reconstructive Neurobiology, Medical Faculty and University Hospital of Bonn, University of Bonn, Bonn, GermanyAuditory Neurophysiology, Department of Chemosensation, Institute for Biology II, RWTH Aachen University, Aachen, GermanyNeural Regeneration, Institute of Reconstructive Neurobiology, Medical Faculty and University Hospital of Bonn, University of Bonn, Bonn, GermanyNeural Regeneration, Institute of Reconstructive Neurobiology, Medical Faculty and University Hospital of Bonn, University of Bonn, Bonn, GermanyNeural Regeneration, Institute of Reconstructive Neurobiology, Medical Faculty and University Hospital of Bonn, University of Bonn, Bonn, GermanyNeural Regeneration, Institute of Reconstructive Neurobiology, Medical Faculty and University Hospital of Bonn, University of Bonn, Bonn, GermanySialic acids are terminal sugars of the cellular glycocalyx and are highly abundant in the nervous tissue. Sialylation is sensed by the innate immune system and acts as an inhibitory immune checkpoint. Aminoglycoside antibiotics such as neomycin have been shown to activate tissue macrophages and induce ototoxicity. In this study, we investigated the systemic subcutaneous application of the human milk oligosaccharide 6’-sialyllactose (6SL) as a potential therapy for neomycin-induced ototoxicity in postnatal mice. Repeated systemic treatment of mice with 6SL ameliorated neomycin-induced hearing loss and attenuated neomycin-triggered macrophage activation in the cochlear spiral ganglion. In addition, 6SL reversed the neomycin-mediated increase in gene transcription of the pro-inflammatory cytokine interleukin-1β (Il-1b) and the apoptotic/inflammatory kinase Pik3cd in the inner ear. Interestingly, neomycin application also increased the transcription of desialylating enzyme neuraminidase 3 (Neu3) in the inner ear. In vitro, we confirmed that treatment with 6SL had anti-inflammatory, anti-phagocytic, and neuroprotective effects on cultured lipopolysaccharide-challenged human THP1-macrophages. Thus, our data demonstrated that treatment with 6SL has anti-inflammatory and protective effects against neomycin-mediated macrophage activation and ototoxicity.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1264060/fullneuroinflammationsialylation6’-sialyllactoseneomycinhearing lossmacrophages
spellingShingle Tawfik Abou Assale
Thomas Kuenzel
Tamara Schink
Anahita Shahraz
Harald Neumann
Christine Klaus
6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
Frontiers in Immunology
neuroinflammation
sialylation
6’-sialyllactose
neomycin
hearing loss
macrophages
title 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
title_full 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
title_fullStr 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
title_full_unstemmed 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
title_short 6’-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
title_sort 6 sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice
topic neuroinflammation
sialylation
6’-sialyllactose
neomycin
hearing loss
macrophages
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1264060/full
work_keys_str_mv AT tawfikabouassale 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice
AT thomaskuenzel 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice
AT tamaraschink 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice
AT anahitashahraz 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice
AT haraldneumann 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice
AT christineklaus 6sialyllactoseamelioratestheototoxiceffectsoftheaminoglycosideantibioticneomycininsusceptiblemice